MedTrace Logo

Tissue Characterization With Hyperspectral Imaging (HSI)

NCT04230603 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2020-09-16

No results posted yet for this study

Summary

Hyperspectral Imaging (HSI) is a contact free method to analyse the from the tissue reflected light in the range of 500-1000nm. Aim of the study is to identify special reflex patterns to identify special tissue

Conditions

  • Tissue Perfusion
  • Tumor
  • Inflammation
  • Inflammatory Bowel Diseases

Interventions

PROCEDURE

Hyperspectral imaging

Photos were taken with the hyperspectral camera of the human tissue

DIAGNOSTIC_TEST

Lactate acid measurement

At the marked regions of the specimen, a lactate acid measurement was performed.

DIAGNOSTIC_TEST

pathological examination

At the marked regions of the specimen, the pathological examination was performed.

Sponsors & Collaborators

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Ines Gockel, MD, Prof. · University of Leipzig

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-06
Primary Completion
2022-01-02
Completion
2022-06-02

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04230603 on ClinicalTrials.gov